Earum Pharmaceuticals Ltd. - Research Center
542724 EARUM-RE Group (R) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Sales | 1.71 | 1.53 | 1.17 | 7.11 | 4.28 |
| Operating profit | -0.66 | 1.20 | 0.14 | 0.06 | -0.48 |
| Interest | 0.26 | 0.15 | 0.14 | - | - |
| Gross profit | -0.26 | 1.06 | 1.39 | 0.06 | 0.39 |
| EPS (Rs) | -0.01 | 0.04 | 0.22 | 0.01 | 0.06 |
Quarterly
results in details
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Other income | 0.66 | - | 1.40 | - | 0.87 |
| Stock adjustment | 0.72 | -1.45 | -0.36 | 0.35 | 0.57 |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.02 | 0.03 | 0.04 | - | - |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.63 | 1.74 | 1.35 | 6.70 | 4.18 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 |
| Taxation | - | 0.77 | - | - | - |
| Net profit / loss | -0.28 | 0.26 | 1.37 | 0.04 | 0.36 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 49.42 | 12.34 | 12.34 | 12.34 | 12.34 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -38.69 | 78.58 | 12.02 | 0.86 | -11.19 |
| GPM (%) | -10.98 | - | 54.41 | - | 7.52 |
| NPM (%) | -11.81 | - | 53.41 | - | 7.06 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis